Biotech to peak very soon GILD $108 CELG $94 Sam Waksal’s about to IPO a new biotech The former ImClone boss who went to prison for an insider trading scandal that also ensnared Martha Stewart said on Wednesday that he plans to take his latest venture, Kadmon, public this year. Waksal is banned from serving as an officer or director of a public company, so he will step down as chairman before the offering and become the chief of innovation, science and strategy. His brother, Harlan, has already taken over as CEO. http://blogs.reuters.com/breakingviews/2014/09/26/sam-waksals-new-biotech-tests-wall-street-amnesia/ Same "investors" that ran to buy BABA will surely line up for this gem.